You are here

Baxdela

FDA OKs new use for Melinta's Baxdela; shares down 26% premarket on potential capital raise

FDA OKs new use for Melinta's Baxdela; shares down 26% premarket on potential capital raise

Seeking Alpha

Melinta Therapeutics

community-acquired bacterial pneumonia

Flag link:

In starved antibiotic field, Melinta soars as FDA grants speedy drug review

In starved antibiotic field, Melinta soars as FDA grants speedy drug review

Endpoints

Melinta Therapeutics

community-acquired bacterial pneumonia

priority review

Flag link:

Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic

Several CEOs and 17 years later, Melinta scores an FDA OK for its antibiotic

Endpoints

Melinta Therapeutics

Flag link: